WELLINGTON MANAGEMENT GROUP LLP - 31 Dec 2024 SCHEDULE 13G/A Report for Crinetics Pharmaceuticals, Inc. Common Stock (CRNX)

Filing Manager
WELLINGTON MANAGEMENT GROUP LLP
Reporting Manager
Wellington Management Group LLP
Security
Crinetics Pharmaceuticals, Inc. Common Stock
Symbol
CRNX
Shares outstanding
92,674,227 shares
Disclosed Ownership
6,950,567 shares
Ownership
7.5%
Form type
SCHEDULE 13G/A
Filing time
10 Feb 2025, 10:25:37 UTC
Date of event
31 Dec 2024
Next filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Wellington Management Group LLP 7.5% 6,950,567 0 6,135,764 Taisia Lowe Regulatory Analyst
Wellington Group Holdings LLP 7.5% 6,950,567 0 6,135,764 Taisia Lowe Regulatory Analyst
Wellington Investment Advisors Holdings LLP 7.5% 6,950,567 0 6,135,764 Taisia Lowe Regulatory Analyst
Wellington Management Company LLP 7.1% 6,950,567 0 6,083,439 Taisia Lowe Regulatory Analyst